Clinical Trials Logo

Filter by:
NCT ID: NCT03655249 Recruiting - Cystic Fibrosis Clinical Trials

Effects of AD on VI in Patients With CF

Start date: August 1, 2018
Phase: N/A
Study type: Interventional

This study will investigate the effects of a chest physiotherapy manual technique (autogenic drainage) on ventilation inhomogeneity in patients with cystic fibrosis. Lung clearance index (LCI) is the primary outcome

NCT ID: NCT03653000 Recruiting - Nerve Block Clinical Trials

Assessement of a Novel Approach to Ultrasound-guided Brachial Plexus Blockade

Start date: April 1, 2021
Phase: N/A
Study type: Interventional

Assessement of a new approach of an ultrasound guided brachial plexus blockade between the infraclavicular and axillary area.

NCT ID: NCT03650114 Recruiting - Clinical trials for Relapsing Multiple Sclerosis

Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS

ALITHIOS
Start date: December 28, 2018
Phase: Phase 3
Study type: Interventional

The purpose of this study is to collect long-term safety, tolerability, effectiveness and health outcomes data in eligible subjects who have participated in a Novartis ofatumumab clinical MS study. Vaccination sub-study The purpose of this research sub-study is to find out the effects of ofatumumab on the development of antibody responses to selected vaccines and keyhole limpet hemocyanin (KLH) neo-antigen in subjects with relapsing multiple sclerosis (RMS).

NCT ID: NCT03649698 Recruiting - Sarcopenia Clinical Trials

Exercise and Nutrition for Healthy AgeiNg

ENHANce
Start date: February 12, 2018
Phase: N/A
Study type: Interventional

The aim of this randomized placebo-controlled 5-arm clinical trial is to evaluate the effect of combined anabolic interventions compared to single or placebo interventions on physical performance in community-dwelling (pre)sarcopenic elderly (≥ 65 years) and to determine the underlying mechanisms of action. Important secondary outcome measures are muscle mass, muscle strength, compliance to the interventions (exercise program, protein and omega-3 supplementation) and functional, cognitive and nutritional status.

NCT ID: NCT03643913 Recruiting - Anesthesia Clinical Trials

The Effect of Deep Neuromuscular Block and Reversal With Sugammadex on Surgical Conditions and Perioperative Morbidity in Shoulder Surgery Using a Deltopectoral Approach

Start date: December 18, 2018
Phase: Phase 4
Study type: Interventional

The study evaluates wether deep neuromuscular block during entire surgical procedure to the gleno-humeral joint or the proximal humerus using a deltoideo-pectoral approach results in less muscular damage to the deltoid muscle and therefore less post-operative pain and an earlier functional recovery..

NCT ID: NCT03642665 Recruiting - Embryo Transfer Clinical Trials

Natural Versus Artificial Cycle for Frozen-Thawed Embryo Transfer

NAFT
Start date: September 25, 2018
Phase: Phase 4
Study type: Interventional

This study evaluates clinical pregnancy rates, obstetrical outcome parameters, costs and patient preferences in natural cycle versus artificial cycle frozen embryo transfers (FET).

NCT ID: NCT03642639 Recruiting - Aneurysms Clinical Trials

A Study to Look at Performance of MICRUSFRAME and GALAXY Coils for the Treatment of Intracranial Aneurysms

STERLING
Start date: August 23, 2018
Phase: N/A
Study type: Interventional

A post-market registry evaluating ruptured/unruptured aneurysms treated with MICRUSFRAME and GALAXY coils

NCT ID: NCT03638115 Recruiting - Clinical trials for Peripheral Artery Disease

The VaSecure BTK Study

Start date: October 30, 2018
Phase: N/A
Study type: Interventional

To assess the safety and performance of the VaSecure drug-coated PTA balloon catheter in the treatment of patients with Chronic Limb Threatening Ischemia (CLTI) of the lower limb below the knee (BTK)

NCT ID: NCT03636295 Recruiting - Clinical trials for Thromboembolism Post-mechanical Valve Replacement

Low INR to Minimize Bleeding With Mechanical Valves Trial

LIMIT
Start date: September 5, 2019
Phase: Phase 3
Study type: Interventional

This study evaluates the use of a lower INR target (1.5 to 2.5) in patients with a mechanical bileaflet heart valve in the aortic position. This study will inform physicians about whether a lower INR target will decrease the risk of bleeding or increase the risk of blood clot formation and stroke. These results have the potential to reduce the burden of bleeding in patients with a mechanical heart valve who require lifelong warfarin (Coumadin) treatment.

NCT ID: NCT03635918 Recruiting - Sleep Apnea Clinical Trials

Extensive Prospective Validation Study of the NightOwl Home Sleep Apnea Test

Start date: August 15, 2018
Phase: N/A
Study type: Interventional

Extensive Prospective validation study of the NightOwl, a Type IV home sleep apnea test (HSAT), compared to traditional PSG and HSAT monitors.